Recent progress in the synthesis of imidazoquinoline derivatives

IF 2.5 Q2 CHEMISTRY, MULTIDISCIPLINARY
Warda Jahangir , Sumayya Akram , Sana Aslam , Matloob Ahmad , Muhammad Shahid Nazir , Sami A. Al-Hussain , Magdi E.A. Zaki
{"title":"Recent progress in the synthesis of imidazoquinoline derivatives","authors":"Warda Jahangir ,&nbsp;Sumayya Akram ,&nbsp;Sana Aslam ,&nbsp;Matloob Ahmad ,&nbsp;Muhammad Shahid Nazir ,&nbsp;Sami A. Al-Hussain ,&nbsp;Magdi E.A. Zaki","doi":"10.1016/j.rechem.2025.102270","DOIUrl":null,"url":null,"abstract":"<div><div>Heterocyclic compounds, ubiquitous in nature and on the synthetic scale, are crucial as they acquire a wide spectrum of significant pharmacological properties. Imidazoquinolines, formed by the annulation of imidazole and quinoline rings dominated drug design and development. Imidazoquinoline hybrids have an extensive range of biological applications such as antiviral, antifungal, anticancer, antibacterial, antiallergic, antioxidant, antithrombotic, as agonists of various toll-like and 5-HT<sub>1A</sub> receptors to treat various CNS disorders, and as inhibitors of phosphoinositide 3-kinases and cholinesterases. This review article explores multiple synthetic approaches for the preparation of imidazoquinoline isomers, including multicomponent, microwave-assisted, iodine-mediated, electrochemical, electrocatalytic tandem techniques, sequential Heck and oxidative amination reactions, cycloaddition and aza-Michael addition reactions, copper-mediated aerobic three-component cyclization reactions, copper-assisted double oxidative C<img>H amination and halogenation, oxidative annulation reactions and Suzuki cross-coupling reactions.</div></div>","PeriodicalId":420,"journal":{"name":"Results in Chemistry","volume":"15 ","pages":"Article 102270"},"PeriodicalIF":2.5000,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Results in Chemistry","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S221171562500253X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0

Abstract

Heterocyclic compounds, ubiquitous in nature and on the synthetic scale, are crucial as they acquire a wide spectrum of significant pharmacological properties. Imidazoquinolines, formed by the annulation of imidazole and quinoline rings dominated drug design and development. Imidazoquinoline hybrids have an extensive range of biological applications such as antiviral, antifungal, anticancer, antibacterial, antiallergic, antioxidant, antithrombotic, as agonists of various toll-like and 5-HT1A receptors to treat various CNS disorders, and as inhibitors of phosphoinositide 3-kinases and cholinesterases. This review article explores multiple synthetic approaches for the preparation of imidazoquinoline isomers, including multicomponent, microwave-assisted, iodine-mediated, electrochemical, electrocatalytic tandem techniques, sequential Heck and oxidative amination reactions, cycloaddition and aza-Michael addition reactions, copper-mediated aerobic three-component cyclization reactions, copper-assisted double oxidative CH amination and halogenation, oxidative annulation reactions and Suzuki cross-coupling reactions.

Abstract Image

咪唑喹啉衍生物的合成研究进展
杂环化合物在自然界和合成领域无处不在,它们具有广泛的重要药理特性,因此至关重要。由咪唑环和喹啉环环化形成的咪唑喹啉类化合物在药物设计和开发中占据主导地位。咪唑喹啉杂化物具有广泛的生物应用,如抗病毒、抗真菌、抗癌、抗菌、抗过敏、抗氧化、抗血栓,还可作为各种收费样受体和 5-HT1A 受体的激动剂治疗各种中枢神经系统疾病,以及作为磷酸肌酸 3- 激酶和胆碱酯酶的抑制剂。这篇综述文章探讨了制备咪唑喹啉异构体的多种合成方法,包括多组分、微波辅助、碘介导、电化学、电催化串联技术、顺序赫克和氧化胺化反应、环加成和偶氮迈克尔加成反应、铜介导的有氧三组分环化反应、铜辅助双氧化CH胺化和卤化反应、氧化环化反应和铃木交叉偶联反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Results in Chemistry
Results in Chemistry Chemistry-Chemistry (all)
CiteScore
2.70
自引率
8.70%
发文量
380
审稿时长
56 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信